Results 1 to 10 of about 90,671 (304)
Transcatheter Aortic Valve Implantation [PDF]
Journal of the American College of Cardiology, 2011 Transcatheter aortic valve implantation (TAVI) was first introduced by Alan Cribier in 2002.1 Since their introduction, the two available devices (the Cribier-Edwards aortic valve [Edwards Lifesciences] and the CoreValve [Medtronic]) have decreased in size and are more flexible, improving deliverability.
Vahanian, Alec +2 more
+11 more sources
Transcatheter Aortic Valve Implantation [PDF]
Journal of Cardiovascular Nursing, 2012 Older adults with progressively worsening aortic valve stenosis are limited in their treatment options. Conventional treatment replaces the aortic valve via open-heart surgery, introducing numerous risks and increased mortality in older populations with comorbidities. In recent years, however, transcatheter aortic valve implantation (tAVI) has become a
Falk, Volkmar, Walther, Thomas
+9 more sources
Transcatheter aortic valve implantation [PDF]
F1000Prime Reports, 2014 Transcatheter aortic valve implantation was developed to offer a therapeutic solution to patients with severe symptomatic aortic stenosis who are not candidates for conventional aortic valve replacement. The improvement in transcatheter aortic valve implantation outcomes is still of concern in the areas of stroke, vascular injury, heart block ...
Oliemy, Ahmed, Al-Attar, Nawwar
+6 more sources
The predictive role of fully revascularized coronary artery disease in patients undergoing transaortic valve implantation [PDF]
Българска кардиология, 2022 In the modern days and the era of the rapid development of medical technology, the introduction of innovative invasive methods of treatment is gradually displacing traditional conventional surgery.
R. Pencheva +6 more
doaj +3 more sources
Transcatheter Aortic Valve Implantation
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2009 There has been significant improvement in device designs, operative techniques, and early clinical outcomes in <5 years. Presently, there are two catheter-based bioprostheses (balloon expandable or self-expandable), which have been widely used in humans and are undergoing clinical investigations.
Jian, Ye, Samuel V, Lichtenstein
+8 more sources
Anatolian Journal of Cardiology, 2022 Background: Data concerning the comparison between transcatheter aortic valve implantation and surgical aortic valve replacement in a real-world setting are scarce and in Central and Eastern Europe no such data exist. In this study, we aimed at analyzing
Krzysztof Wilczek +12 more
doaj +1 more source
Management of patients with transcatheter implantable aortic valve
Klinicist, 2023 Valvular heart disease remains one of the causes of cardiovascular morbidity and mortality worldwide. Aortic stenosis is the most common valvular pathology requiring cardiac surgery.
E. B. Luneva, E. G. Malev
doaj +1 more source
Osaka Prognostic Score Predicts In-Hospital and One-Year Mortality Following Transcatheter Aortic Valve Implantation. [PDF]
Medicina (Kaunas)Akdoğan M +9 more
europepmc +3 more sources
Transapical transcatheter aortic valve implantation in a patient with small body weight complicated by severe hypotension: An enigma successfully solved by echocardiography [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2017 Introduction. Transcatheter aortic valve implantation is currently considered an alternative treatment for older patients with severe aortic valve stenosis and increased surgical risk, but can be associated with multiple life-threatening complications ...
Lazarević Aleksandar +6 more
doaj +1 more source
Advances in Transcatheter Electrosurgery for Treating Valvular Heart Disease
US Cardiology Review, 2021 Delivery of electrosurgery energy through catheters and guidewires enables interventionists to ‘cut’ through obstructive intravascular lesions or across cardiac chambers.
Jaffar M Khan +9 more
doaj +1 more source